Chemotherapy
Introduction
Chemotherapy is one of the most established and widely used treatments in modern oncology. It plays a central role across solid cancers and haematological malignancies, either alone or in combination with surgery, radiation therapy, targeted therapy, and immunotherapy. While its core principle—destroying rapidly dividing cancer cells—has remained unchanged, the manner in which chemotherapy is selected, delivered, monitored, and supported has evolved dramatically.
At our clinic, chemotherapy is delivered using a precision-based, evidence-driven, and patient-centred model. This includes multidisciplinary decision-making, guideline-based regimen selection, structured toxicity monitoring, and comprehensive supportive care—all aligned with our core values of Cure, Precision, and Compassion.
1. What Is Chemotherapy?
Chemotherapy refers to a group of cytotoxic drugs designed to kill or inhibit the growth of cancer cells. Because cancer cells divide rapidly and uncontrollably, chemotherapy targets this core property. Unlike targeted therapy or immunotherapy, chemotherapy acts broadly and does not depend on the presence of specific genetic mutations.
How Chemotherapy Works
Different classes of chemotherapy drugs damage cancer cells through different mechanisms:
The choice of drug, dose, and combination depends on tumour biology, stage, patient fitness, and treatment goals.
2. Why Chemotherapy Is Used
Chemotherapy has multiple roles in cancer care:
How Chemotherapy Works
Certain cancers such as lymphomas, testicular cancer, childhood leukemias, and some solid tumours can be cured with chemotherapy alone or in combination with other modalities.
Neoadjuvant Therapy
Administered before surgery, chemotherapy can shrink tumours, making surgery easier and more effective. It also allows early treatment of microscopic disease.
Examples: breast cancer, oesophageal cancer, bladder cancer, sarcomas.
Adjuvant Therapy
Given after surgery, chemotherapy eliminates microscopic residual cancer cells and reduces the risk of recurrence.
Concurrent Chemoradiation
Some chemotherapy drugs act as radiosensitisers and enhance the effectiveness of radiation therapy.
Examples: head and neck cancer, cervical cancer, rectal cancer, lung cancer.
Palliative or Disease-Control Therapy
In advanced cancers, chemotherapy helps slow progression, reduce symptoms, and improve quality of life.
3. How Chemotherapy Is Given
Chemotherapy can be delivered in several ways:
Treatment is structured into cycles, which repeat every 1, 2, or 3 weeks, depending on the regimen. The number of cycles depends on cancer type and response.
Our Chemotherapy Day-Care Facility
To ensure safety and comfort, we offer:
4. Personalising Chemotherapy
Modern chemotherapy is no longer “one size fits all.” Personalisation includes:
1. Multidisciplinary Tumor Board Decisions
Surgeons, medical oncologists, radiologists, pathologists, and supportive-care experts collaborate to determine the best regimen.
2. Individualised Dose Modifications
Doses may be adjusted based on:
3. Integrating Genomic and Molecular Reports
While chemotherapy itself is not mutation-dependent, genetic profiling guides whether chemotherapy is needed, and in what sequence, especially in breast, colorectal, and lung cancers.
4. Supportive Care Tailored to the Patient
Prophylactic medicines such as antiemetics, growth factors, hydration protocols, and cardioprotective strategies are adjusted according to risk.
5. Potential Side Effects
Chemotherapy affects normal rapidly dividing cells, which is why side effects occur. Understanding them helps patients anticipate, report, and manage symptoms effectively.
Common Side Effects
Serious but Less Common Side Effects
Our Supportive-Care Approach
We use internationally recommended strategies to minimise toxicity:
6. Safety, Monitoring, and Quality Control
Chemotherapy requires precise planning and strict adherence to safety standards.
Before Each Cycle
During Treatment
After Treatment
We adhere to NCCN, ESMO, ASCO, and national guidelines to deliver safe and effective chemotherapy.
7. Living During Chemotherapy
Diet and Hydration
Patients are encouraged to eat small, frequent meals rich in protein and calories. Hydration is crucial.
Activity and Exercise
Moderate physical activity helps maintain strength, reduce fatigue, and support recovery.
Infection Prevention
Mental Health Support
Many patients experience anxiety or uncertainty. Our team provides:
Sexual Health and Fertility
Conversations about fertility preservation and hormonal changes are part of our holistic approach.
8. Chemotherapy Outcomes
Outcome depends on:
For some cancers, chemotherapy is curative. For others, it enhances survival, reduces recurrence risk, or improves quality of life. When delivered using modern protocols and multidisciplinary care, chemotherapy is safer and more effective than ever.
Conclusion
Chemotherapy remains a cornerstone of cancer treatment. At our clinic, it is delivered using the highest standards of medical evidence, safety, and personalised care. Every plan is designed with the patient’s prognosis, comfort, goals, and overall well-being at the centre.
We bring together scientific precision, clinical experience, and compassionate care—ensuring that patients receive the most appropriate chemotherapy regimen with the greatest possible safety and support.
Targeted Therapy
Precision Medicine for Modern Cancer Care
Introduction
Targeted therapy represents one of the most transformative advancements in oncology. Unlike chemotherapy—which attacks rapidly dividing cells—targeted therapies act on specific molecular pathways, genetic mutations, or cellular receptors that drive cancer growth. This precision-based approach allows for more effective treatment with fewer systemic side effects and has significantly improved survival in multiple cancers.
At our clinic, targeted therapy is delivered through an evidence-based, biomarker-driven, and patient-centred framework. Advanced diagnostics, multidisciplinary tumour board review, and detailed monitoring ensure that every patient receives treatment aligned with their tumour biology and personal goals of care. This page provides a detailed yet accessible overview for both patients and clinicians.
1. What Is Targeted Therapy?
Targeted therapy refers to drugs that specifically block molecules or pathways essential for cancer cell survival and proliferation. These drugs recognise abnormalities unique to cancer cells, such as:
By acting on these drivers, targeted therapies disrupt the core mechanisms that allow cancer cells to grow, invade, and spread.
2. How Targeted Therapy Works
Targeted therapy interferes with cancer biology in several ways. The most common categories include:
1. Tyrosine Kinase Inhibitors (TKIs)
These oral drugs block abnormal signalling pathways inside cancer cells.
Examples:
2. Monoclonal Antibodies (mAbs)
These are lab-designed antibodies that bind to specific receptors on cancer cells.
Examples:
3. Angiogenesis Inhibitors
These drugs block the formation of blood vessels that tumours need for growth.
Examples:
4. PARP Inhibitors
Used in BRCA-mutated cancers, these drugs exploit DNA repair weaknesses in cancer cells.
Examples:
5. mTOR and PI3K Pathway Inhibitors
These block pathways involved in cell metabolism and growth.
6. Hormone-Signalling Modifiers
In some classifications, these are grouped separately as hormonal therapy, but they also work through targeted mechanisms.
3. Who Is Eligible for Targeted Therapy?
Targeted therapy is not given based on tumour site alone—it depends on molecular testing. This is the foundation of precision oncology.
Essential Investigations Include:
Common Actionable Biomarkers
Not all patients will have an actionable mutation. In such cases, alternative treatments including chemotherapy, immunotherapy, or surgery may be more appropriate.
4. Why Targeted Therapy Is Used
1. Higher Precision
Because the drugs act on specific molecular abnormalities, they spare most healthy tissues.
2. Better Tolerability
Compared to traditional chemotherapy, many targeted therapies have more predictable and manageable side effect profiles
3. Increased Effectiveness in Select Cancers
Targeted therapies have transformed outcomes in:
4. Suitable for Long-Term Disease Control
Many targeted therapies are taken orally, sometimes for months or years, offering sustained cancer control and improved quality of life.
5. How Targeted Therapy Is Given
Targeted therapy can be administered in two main ways:
Oral Targeted Therapy
Many TKIs are taken as daily tablets or capsules.
Advantages:
Intravenous Targeted Therapy
Monoclonal antibodies and some inhibitors are given as IV infusions.
Examples:
These are administered in our chemotherapy day-care suite under strict monitoring.
6. Side Effects of Targeted Therapy
Although more selective, targeted therapies are not free of side effects. Each drug class has a characteristic toxicity profile.
Common Side Effects
Less Common but Significant Effects
For some cancers, chemotherapy is curative. For others, it enhances survival, reduces recurrence risk, or improves quality of life. When delivered using modern protocols and multidisciplinary care, chemotherapy is safer and more effective than ever.
Monitoring Plan
We monitor patients with:
Early detection allows us to adjust doses promptly and maintain safety.
7. Personalising Targeted Therapy
Although more selective, targeted therapies are not free of side effects. Each drug class has a characteristic toxicity profile.
1. Tumour Biomarker Profile
No genomic alteration → no targeted therapy
Actionable mutation → appropriate matched drug
2. Cancer Stage and Burden
Advanced cancers may need combination therapy.
3. Performance Status
Oral therapy is often preferred in frail or elderly patients.
4. Toxicity Risk
Individual comorbidities guide drug selection and dosing.
5. Interaction with Other Treatments
Targeted therapy may be used:
Our multidisciplinary tumour board ensures that treatment sequencing is optimised for every patient.
8. Life During Targeted Therapy
Diet
Most targeted therapies do not require special diets, but patients should maintain balanced nutrition.
Exercise
Moderate physical activity improves energy levels and overall well-being.
Monitoring Symptoms
Patients are advised to promptly report:
Medication Interactions
Some TKIs interact with common medications such as antacids, antifungals, or blood thinners. Our team reviews all existing medications before starting therapy.
9. Success Rates and Outcomes
The impact of targeted therapy varies by cancer type and mutation, but in many diseases, outcomes have improved dramatically.
Examples:
Early identification of actionable mutations is crucial, which is why we integrate molecular testing early in the treatment pathway.
10. Why Our Clinic’s Approach Is Distinct
Precision-Based Treatment
Molecular profiling, liquid biopsy, and advanced diagnostics guide treatment selection.
Multidisciplinary Decision-Making
Oncologists, surgeons, radiologists, and pathologists jointly evaluate every case.
Rigorous Monitoring Protocols
Safety checks, labs, and imaging are done at regular intervals.
Patient Education
Detailed counselling helps patients understand expectations, benefits, and precautions.
Holistic Care
Nutrition, psychological support, and symptom management are integrated throughout therapy.
Our goal is to combine scientific accuracy with human-centred care, ensuring the best possible experience and outcomes.
Conclusion
Targeted therapy has reshaped cancer treatment, offering powerful and precise options for patients whose tumours carry specific molecular abnormalities. When delivered through a structured, evidence-based approach, these therapies offer improved outcomes, better tolerability, and longer-lasting control of disease.
At our clinic, we bring together precision diagnostics, expert multidisciplinary planning, and compassionate patient support to ensure that every targeted therapy plan is both scientifically sound and deeply personalised.
Immunotherapy
Harnessing the Body’s Own Defence System to Fight Cancer
Introduction
Immunotherapy has revolutionised the field of oncology by shifting the focus from directly attacking cancer cells to empowering the immune system to recognise and eliminate them. It represents one of the most significant breakthroughs in cancer treatment in recent decades, offering long-lasting responses—even in advanced or previously untreatable cancers.
At our clinic, immunotherapy is delivered through a precision-driven, evidence-based approach supported by molecular diagnostics, multidisciplinary evaluation, and comprehensive patient monitoring. This ensures that every patient receives a personalised treatment plan aligned with the latest scientific data and their individual goals.
1. What Is Immunotherapy?
Immunotherapy refers to treatments that activate, enhance, or restore the immune system’s ability to detect and destroy cancer cells. Cancer often evades immune detection by exploiting pathways that suppress immune responses. Immunotherapy counteracts these mechanisms and reawakens the body's natural defence system.
Unlike chemotherapy, which kills rapidly dividing cells, or targeted therapy, which blocks specific molecular pathways, immunotherapy enhances the immune response—which can then provide sustained control of cancer even after treatment ends.
2. Types of Immunotherapy
There are several forms of immunotherapy, each designed to act on specific components of the immune system.
1. Immune Checkpoint Inhibitors (ICIs)
Checkpoints are natural “off switches” that prevent the immune system from attacking normal cells. Cancers exploit these checkpoints to hide from the immune system.
Checkpoint inhibitors block these signals and allow immune cells—particularly T-cells—to attack cancer.
Examples:
These therapies are widely used in lung cancer, melanoma, kidney cancer, bladder cancer, triple-negative breast cancer, and head & neck cancers.
2. CAR-T Cell Therapy
A highly specialised treatment in which a patient’s own T-cells are genetically engineered to recognise cancer cells.
Used mainly in leukaemia, lymphoma, and myeloma.
(Note: CAR-T will have a separate detailed page, as per your list.)
3. Cancer Vaccines
Therapeutic vaccines stimulate the immune system to attack cancer cells.
Examples: HPV vaccine prevents cervical and oropharyngeal cancers.
4. Cytokine Therapy
Cytokines like interleukin-2 (IL-2) amplify the immune response. These are now used less frequently but remain important in specific settings such as renal cell carcinoma.
5. Oncolytic Virus Therapy
Modified viruses infect and destroy cancer cells while stimulating an immune response.
3. Who Is Eligible for Immunotherapy?
Immunotherapy is not appropriate for every patient. Eligibility is determined through clinical evaluation and biomarker testing.
Key Biomarkers and Tests
Cancers Where Immunotherapy Is Commonly Used
Immunotherapy may be used alone, in combination with chemotherapy, or as part of multimodality treatment.
4. How Immunotherapy Works
Cancer cells employ multiple tactics to escape the immune system, such as:
Immunotherapy reverses these mechanisms by:
This results in a more durable and adaptive anti-cancer response.
5. How Immunotherapy Is Given
Immunotherapy is typically administered as:
Treatment duration varies by disease:
Infusions occur in our day-care treatment suite under oncologist supervision. Pre-infusion assessment and post-infusion observation are routine to ensure safety.
6. Potential Side Effects
Immunotherapy is generally better tolerated than chemotherapy. However, because it activates the immune system, it can sometimes cause the immune system to attack normal organs—these are called immune-related adverse events (irAEs).
Common Side Effects
Immune-Related Adverse Events (irAEs)
These can affect any organ system:
Management of Side Effects
Early recognition is crucial. Treatment may include:
At our clinic, we follow internationally accepted toxicity management guidelines (ASCO, NCCN, ESMO).
7. Monitoring During Immunotherapy
Regular monitoring helps ensure efficacy and safety.
Before Each Cycle
During Treatment
After Completion
Targeted therapy may be used:
We use a coordinated, multidisciplinary monitoring system involving oncologists, pulmonologists, endocrinologists, cardiologists, and supportive-care specialists when needed.
8. Unique Benefits of Immunotherapy
1. Potential for Long-term Remission
Many patients achieve durable responses, even after treatment stops.
2. Effective in Certain High-Risk Cancers
Immunotherapy has changed outcomes dramatically in melanoma, lung cancer, and several solid tumours.
3. Works Even After Failure of Chemotherapy
Immunotherapy can sometimes succeed where chemotherapy has not.
4. Often Better Tolerated
Fewer systemic side effects compared to chemotherapy.
5. Immunological Memory
The immune system may “remember” cancer cells, reducing chances of recurrence.
9. Limitations of Immunotherapy
Although powerful, immunotherapy has limitations:
Our team evaluates every patient rigorously to determine whether immunotherapy is truly the best option.
10. Living During Immunotherapy
General Well-being
Most patients can continue daily activities, including work, exercise, and travel, with appropriate precautions.
Diet and Hydration
A balanced diet supports energy, immunity, and recovery.
Infection Precautions
Immunotherapy itself does not suppress immunity like chemotherapy, but vigilance is still advised.
When to Seek Urgent Care
Early recognition prevents complications.
11. Our Clinic’s Approach to Immunotherapy
Precision-Based Eligibility Assessment
We use PD-L1, MSI/MMR, TMB, and other biomarkers to identify eligible patients.
Multidisciplinary Evaluation
Treatment plans are finalised after tumour board discussions.
Evidence-Based Protocols
Treatment follows NCCN, ASCO, and ESMO guidelines combined with real-world clinical experience.
Holistic Support
Transparent Communication
Patients receive clear counselling on expected benefits, risks, timelines, and monitoring.
Conclusion
Immunotherapy marks a new era in cancer treatment—one that focuses on harnessing the body’s natural defences for long-lasting results. While not suitable for every patient, when used appropriately and monitored carefully, immunotherapy offers powerful and durable control over many cancers.
At our clinic, we bring together expertise, precision diagnostics, multidisciplinary collaboration, and compassionate care to deliver safe, effective, and personalised immunotherapy to each patient who can benefit.
CAR-T Cell Therapy
Cutting-Edge, Personalised Immunotherapy for Blood Cancers
Introduction
Chimeric Antigen Receptor T-Cell Therapy—commonly known as CAR-T cell therapy—is one of the most advanced, personalised forms of cancer treatment available today. Unlike chemotherapy, targeted therapy, or standard immunotherapy, CAR-T uses the patient’s own immune cells, genetically engineers them to recognise cancer, and re-infuses them to launch a focused attack on malignant cells.
This approach has revolutionised outcomes in several blood cancers, especially in patients whose disease has relapsed multiple times or become resistant to conventional treatments. CAR-T therapy represents the frontier of precision oncology and offers new hope when traditional treatment options have been exhausted.
At our clinic, CAR-T therapy is offered through specialised referral networks and accredited centres, ensuring stringent selection, rigorous monitoring, and comprehensive pre- and post-treatment support.
1. What Is CAR-T Cell Therapy?
CAR-T therapy is a highly individualised treatment that involves modifying a patient’s own T-cells (a type of white blood cell) to attack cancer. The treatment involves:
CAR-T therapy gives the immune system a “new set of instructions” to fight cancer more effectively.
2. How CAR-T Cells Work
Cancer cells often avoid detection by hiding their antigens or suppressing the immune system. CAR-T therapy bypasses these escape mechanisms.
Mechanism of Action
This makes CAR-T cell therapy fundamentally different from most traditional treatments.
3. Cancers Treated with CAR-T Therapy
Currently, CAR-T therapy is primarily used in haematological malignancies.
Approved Indications Include:
Research is ongoing for applications in:
However, these are still investigational.
4. Steps in CAR-T Therapy
The CAR-T process typically takes several weeks and involves multiple stages.
1. Patient Evaluation
A multidisciplinary team assesses:
Not all patients are suitable candidates, especially those with severe organ dysfunction or rapidly progressing disease.
2. T-Cell Collection (Leukapheresis)
Blood is passed through a machine that isolates T-cells, while the rest of the blood returns to the body.
3. Genetic Engineering
In a controlled laboratory facility:
4. Cell Expansion
Millions to billions of CAR-T cells are grown in the lab over 2–3 weeks.
5. Lymphodepleting Chemotherapy
Before infusion, patients receive low-dose chemotherapy to:
This is not high-intensity chemotherapy.
6. CAR-T Cell Infusion
CAR-T cells are infused in a single, controlled setting.
This is similar to a blood transfusion.
7. Monitoring and Support
Patients are monitored closely for side effects, usually requiring hospital admission for 7–14 days.
5. Benefits of CAR-T Therapy
1. High Response Rates in Refractory Disease
Many patients who have failed multiple lines of treatment can achieve:
2. Potential for Long-Term Cure
CAR-T cells can persist and continue protecting the patient.
3. Personalised Treatment
Because CAR-T is made from the patient’s own cells, it is tailored uniquely for each individual.
4. Single Administration
Unlike chemotherapy cycles, CAR-T therapy is typically a one-time infusion.
5. Deeper Responses
CAR-T cells can reach cancer cells in locations where chemotherapy may be ineffective.
6. Potential Risks and Side Effects
CAR-T therapy is powerful, but its immune activation can lead to significant side effects that require expert management.
1. Cytokine Release Syndrome (CRS)
The most common side effect.
Symptoms Include:
Management includes:
2. Immune Effector Cell–Associated Neurotoxicity Syndrome (ICANS)
A unique neurological toxicity.
Symptoms:
3. Infections
Due to immune suppression.
4. Low Blood Counts
Temporary but common.
5. Tumour Lysis Syndrome
Rapid cancer cell death leading to electrolyte imbalances.
Our Safety Protocols Include:
CAR-T therapy requires specialist infrastructure; we coordinate care with accredited centres to ensure safety.
7. Follow-Up and Recovery After CAR-T Therapy
Recovery continues for weeks to months.
Short-Term Follow-Up
Long-Term Follow-Up
Patients often continue prophylactic medications to prevent infections.
8. Who Is Not Eligible for CAR-T Therapy?
CAR-T may not be suitable for patients with:
Our clinical team conducts a detailed evaluation before proceeding.
9. CAR-T vs Other Treatments
CAR-T is not a replacement for chemotherapy or immunotherapy but rather a specialised therapy for selected patients.
10. Our Clinic’s Role in CAR-T Therapy
We provide a complete, structured pathway for patients requiring CAR-T:
1. Patient Evaluation and Selection
Detailed assessment by our haematology and medical oncology experts.
2. Pre-CAR-T Preparation
3. Seamless Referral and Monitoring
We collaborate with accredited CAR-T treatment centres and manage:
4. Psychosocial, Nutritional, and Family Support
CAR-T therapy is emotionally demanding. We support patients and caregivers throughout the process.
5. Survivorship Planning
Long-term monitoring and holistic care beyond remission.
Conclusion
CAR-T cell therapy represents a landmark shift in cancer treatment. For selected patients with relapsed or refractory blood cancers, it offers deep, durable responses and the possibility of long-term remission—even after multiple previous treatment failures.
Our clinic ensures that every patient considered for CAR-T therapy receives expert evaluation, comprehensive counselling, and coordinated, high-quality care throughout the entire treatment journey. With a commitment to Cure, Precision, and Compassion, we guide patients through every stage of this advanced, life-changing therapy.
Hormonal Therapy
Targeting Hormone-Driven Cancers with Precision and Personalised Care
Introduction
Hormonal therapy—also known as endocrine therapy—is a cornerstone of treatment for cancers that depend on hormones such as estrogen, progesterone, or testosterone for growth. Unlike chemotherapy, which attacks rapidly dividing cells, or targeted therapy, which focuses on specific genetic mutations, hormonal therapy works by blocking hormone production, interfering with receptor signalling, or suppressing hormonal stimulation of cancer cells.
This approach is most effective in hormone-driven cancers such as breast cancer and prostate cancer, where it significantly improves survival, reduces recurrence, and allows long-term disease control. At our clinic, hormonal therapy is delivered with precise evaluation of tumour biology, individual risk assessment, and a strong integration of supportive care—all aligned with our commitment to Cure, Precision, and Compassion.
1. What Is Hormonal Therapy?
Hormonal therapy (endocrine therapy) is a treatment that interferes with the production or function of hormones that can promote cancer growth. Many cancers—especially breast and prostate cancers—are “hormone-sensitive,” meaning they grow in response to specific hormones.
Common Hormone-Sensitive Cancers
Hormonal therapy can be used as a standalone treatment or combined with surgery, chemotherapy, radiation therapy, and targeted therapy.
2. How Hormonal Therapy Works
Hormonal therapy works through three primary mechanisms:
1. Reducing Hormone Levels
Some drugs suppress hormone production in the ovaries or testicles:
2. Blocking Hormone Receptors
These medications prevent hormones from binding to their receptors on cancer cells:
3. Inhibiting Hormone Formation in Peripheral Tissues
Aromatase inhibitors (letrozole, anastrozole, exemestane) prevent estrogen formation in postmenopausal women.
This targeted approach starves cancer cells of the hormones they need to grow.
3. Hormonal Therapy in Breast Cancer
Hormonal therapy is the backbone of treatment for ER-positive and PR-positive breast cancers, which represent 70–80% of all breast cancer cases.
Common Agents
Treatment Settings
Duration
Typically 5–10 years, depending on menopausal status, risk factors, and disease stage.
Combination Approaches
Hormonal therapy is often combined with:
These combinations significantly improve outcomes in advanced disease.
4. Hormonal Therapy in Prostate Cancer
Prostate cancer is driven by androgens, primarily testosterone. Hormonal therapy—known as Androgen Deprivation Therapy (ADT)—is therefore central to its management.
Forms of ADT
1. LHRH agonists/antagonists – suppress testosterone production
2. Anti-androgens
3. Androgen synthesis inhibitors
Clinical Uses
Combination Therapy
ADT is often combined with chemotherapy (docetaxel) or novel hormonal agents for improved survival.
5. Hormonal Therapy in Other Cancers
Endometrial Cancer
Progestins and aromatase inhibitors may be used in early-stage disease or in recurrent settings.
Ovarian Cancer
Hormonal therapy is sometimes used in low-grade serous or ER-positive ovarian cancers.
Thyroid Cancer
TSH suppression with levothyroxine reduces recurrence risk in some cases.
6. How Hormonal Therapy Is Administered
Hormonal therapy may be given as:
Treatment is typically long-term and requires regular monitoring.
7. Side Effects of Hormonal Therapy
Side effects depend on the therapy used and the hormones being suppressed.
A. Breast Cancer Hormonal Therapy Side Effects
Tamoxifen
Aromatase Inhibitors
Ovarian Suppression
B. Prostate Cancer Hormonal Therapy Side Effects
Mitigation Strategies
We integrate structured supportive care:
8. Monitoring During Hormonal Therapy
Monitoring is essential to ensure safety and measure effectiveness.
For Breast Cancer
For Prostate Cancer
Adjustments are made based on side effects, comorbidities, and treatment goals.
9. Advantages of Hormonal Therapy
1. Highly Effective
Hormonal therapy significantly reduces recurrence and improves survival in hormone-sensitive cancers.
2. Favourable Tolerability
Compared to chemotherapy, side effects are often milder and more manageable.
3. Long-Term Disease Control
Many patients can live years with stable disease using hormonal therapy alone or in combination with targeted agents.
4. Oral & Convenient
Most hormonal therapies are taken at home and require fewer hospital visits.
5. Suitable for Older Patients
Well-tolerated even in patients with comorbidities when used appropriately.
10. Limitations of Hormonal Therapy
Our clinic provides continuous education and follow-up to ensure safe, effective, and consistent therapy.
11. Our Clinic’s Approach to Hormonal Therapy
1. Precision-Based Decision-Making
We evaluate:
2. Multidisciplinary Tumour Board
Surgical, medical, radiation, and pathology specialists collaborate to select the optimal endocrine strategy.
3. Personalised Treatment Plans
Doses, agents, and durations are tailored to each patient.
4. Comprehensive Supportive Care
5. Clear Communication
Patients receive detailed counselling on expectations, risks, and long-term follow-up.
Conclusion
Hormonal therapy remains one of the most effective and widely used treatments for hormone-driven cancers. When selected correctly and supported with careful monitoring, it offers long-term control with excellent quality of life. At our clinic, we deliver hormonal therapy with a commitment to scientific rigor, personalised care, and patient well-being—embodying our philosophy of Cure, Precision, and Compassion.
